# Correction to: Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors

PMC · DOI: 10.1093/oncolo/oyaf366 · 2026-01-29

## Full-text entities

- **Diseases:** solid tumors (MESH:D009369)
- **Chemicals:** SPH4336 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12855602